Intermolecular Inc (IMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | |
| Sales | 23,129 |
| Cost of Goods | 12,625 |
| Gross Profit | 10,504 |
| Operating Expenses | 20,623 |
| Operating Income | -9,494 |
| Other Income | 180 |
| Pre-tax Income | -9,314 |
| Income Tax | 186 |
| Net Income Continuous | -9,500 |
| Net Income | $-9,500 |
| EPS Basic Total Ops | -1.39 |
| EPS Basic Continuous Ops | -0.89 |
| EPS Diluted Total Ops | -1.39 |
| EPS Diluted Continuous Ops | -0.89 |
| EBITDA(a) | $-6,064 |